Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

Background: To analyse the discriminative impact of osteopontin (OPN) and activated leukocyte cell adhesion molecule (ALCAM), combined with human epidermal growth factor 2 (HER2) and oestrogen receptor (ER) in breast cancer. Methods: Osteopontin, ALCAM, HER2 and ER mRNA expression in breast cancer t...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	British journal of cancer 2010-09, Vol.103 (7), p.1048-1056
Hauptverfasser:	Ihnen, M, Wirtz, R M, Kalogeras, K T, Milde-Langosch, K, Schmidt, M, Witzel, I, Eleftheraki, A G, Papadimitriou, C, Jänicke, F, Briassoulis, E, Pectasides, D, Rody, A, Fountzilas, G, Müller, V
Format:	Artikel
Sprache:	eng
Schlagworte:	692/53/2422 692/699/67/1059/602 692/699/67/1347 Activated-Leukocyte Cell Adhesion Molecule - genetics Adult Aged Biological and medical sciences Biomedical and Life Sciences Biomedicine Breast cancer Breast Neoplasms - genetics Breast Neoplasms - mortality Cancer Research Cancer therapies Cell adhesion & migration Chemotherapy Cluster Analysis Decision Trees Disease-Free Survival Drug Resistance Epidemiology Epidermal growth factor Eukaryotic Initiation Factor-3 Female Genes Gynecology Gynecology. Andrology. Obstetrics Hospitals Humans Leukocytes Mammary gland diseases Medical prognosis Medical research Medical sciences Middle Aged Molecular Diagnostics Molecular Medicine Obstetrics Oligonucleotide Array Sequence Analysis Oncology Osteopontin - genetics Patients Prognosis Receptor, ErbB-2 - genetics Receptors, Estrogen - genetics Risk RNA, Messenger - metabolism Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!